Regenerative Research Foundation
Regenerative Research Foundation shows consistent revenue growth and no reported officer compensation across all filings.
EIN: 203654626 · Albany, NY · NTEE: H96 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $7.0M |
| Total Expenses | $7.3M |
| Program Spending | 90% |
| CEO/Top Officer Pay | $8.7 |
| Net Assets | $5.5M |
| Transparency Score | 85/100 |
Is Regenerative Research Foundation Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Regenerative Research Foundation directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Regenerative Research Foundation
Regenerative Research Foundation (EIN: 203654626) is a nonprofit organization based in Albany, NY, classified under NTEE code H96. The organization reported total revenue of $7.0M and total assets of $9.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Regenerative Research Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Regenerative Research Foundation is a mid-size nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 7.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $8.8M |
| Total Expenses | $7.3M |
| Surplus / Deficit | +$1.5M |
| Total Assets | $7.0M |
| Total Liabilities | $1.5M |
| Net Assets | $5.5M |
| Operating Margin | 16.9% |
| Debt-to-Asset Ratio | 21.2% |
| Months of Reserves | 11.5 months |
Financial Health Grade: A
In 2023, Regenerative Research Foundation reported a surplus of $1.5M with revenue exceeding expenses, holds 11.5 months of operating reserves (strong position), has a debt-to-asset ratio of 21.2% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Regenerative Research Foundation's revenue has grown at a compound annual growth rate (CAGR) of 7.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +16.8% | +24.9% | +17.0% |
| 2022 | +47.7% | +26.8% | +32.4% |
| 2021 | +42.6% | +24.0% | +77.1% |
| 2020 | +1.2% | +0.5% | +11.2% |
| 2019 | +8.7% | -3.7% | -10.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2100 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Regenerative Research Foundation with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Regenerative Research Foundation allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.5M, with revenue exceeding expenses.
- Debt-to-asset ratio: 21.2%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is highly unusual for an organization of its size with revenues reaching $8.7 million. This suggests either a fully volunteer-led executive team or that executive compensation is categorized differently, warranting further investigation for full transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Regenerative Research Foundation's IRS 990 filings:
- Consistent 0% reported officer compensation, which is unusual for an organization of this scale and could indicate a lack of transparency if compensation exists but is not reported under this specific line item.
Strengths
The following positive indicators were identified for Regenerative Research Foundation:
- Strong and consistent revenue growth, increasing from $3.5 million in 2019 to $8.7 million in 2023.
- Positive net income in recent years, with revenue exceeding expenses (e.g., $8.7M revenue vs. $7.3M expenses in 202312).
- Growing asset base, indicating financial stability and capacity for future programs, with assets reaching $6.9 million in 202312.
- Low liabilities relative to assets, suggesting good financial health and limited debt burden (e.g., $1.4M liabilities vs. $6.9M assets in 202312).
Frequently Asked Questions about Regenerative Research Foundation
Is Regenerative Research Foundation a legitimate charity?
Regenerative Research Foundation (EIN: 203654626) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $7.0M. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does Regenerative Research Foundation spend its money?
Regenerative Research Foundation directs 90% of its spending to programs and services. Fundraising costs 3%. This exceeds the 65% industry benchmark.
Are donations to Regenerative Research Foundation tax-deductible?
Regenerative Research Foundation is registered as a tax-exempt nonprofit (EIN: 203654626). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Regenerative Research Foundation CEO make?
Regenerative Research Foundation's highest-compensated officer earns $8.7 annually. The organization reported $7.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Regenerative Research Foundation's spending goes to programs?
Regenerative Research Foundation directs 90% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Regenerative Research Foundation compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Regenerative Research Foundation is above average for NTEE category H96 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Regenerative Research Foundation located?
Regenerative Research Foundation is headquartered in Albany, New York and files with the IRS under EIN 203654626. It is classified under NTEE code H96.
How many years of IRS 990 filings does Regenerative Research Foundation have?
Regenerative Research Foundation has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $7.0M in total revenue.
How does Regenerative Research Foundation manage to operate without reporting any officer compensation?
The IRS 990 filings consistently show 0% officer compensation. This could mean that executive leadership is entirely volunteer-based, or that compensation is reported under other expense lines, or paid by an affiliated entity. Further inquiry into their operational model would be needed to understand this structure.
What is the primary use of the increasing assets held by the organization?
The organization's assets have grown significantly, from $2,293,624 in 201912 to $6,996,425 in 202312. While the filings indicate accumulation, the specific deployment of these assets (e.g., research facilities, endowments, operational reserves) would require reviewing the full 990 forms for detailed balance sheet information.
Is the organization's revenue growth sustainable?
Regenerative Research Foundation has shown strong revenue growth, from $3,531,037 in 201912 to $8,795,245 in 202312. This consistent upward trend suggests a robust fundraising or grant acquisition strategy, indicating sustainability in the short to medium term, assuming current funding sources remain stable.
Filing History
IRS 990 filing history for Regenerative Research Foundation showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Regenerative Research Foundation's revenue has grown by 145.5%, moving from $3.6M to $8.8M. Total assets increased by 183% over the same period, from $2.5M to $7.0M. Total functional expenses rose by 162.4%, from $2.8M to $7.3M. In its most recent filing year (2023), Regenerative Research Foundation reported a surplus of $1.5M, with revenue exceeding expenses. The organization holds $1.5M in liabilities against $7.0M in assets (debt-to-asset ratio: 21.2%), resulting in net assets of $5.5M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $8.8M | $7.3M | $7.0M | $1.5M | — | View 990 |
| 2022 | $7.5M | $5.8M | $6.0M | $2.0M | — | View 990 |
| 2021 | $5.1M | $4.6M | $4.5M | $2.2M | — | View 990 |
| 2020 | $3.6M | $3.7M | $2.6M | $700K | — | — |
| 2019 | $3.5M | $3.7M | $2.3M | $298K | — | View 990 |
| 2018 | $3.2M | $3.8M | $2.6M | $410K | — | View 990 |
| 2017 | $4.9M | $5.8M | $3.4M | $614K | — | View 990 |
| 2016 | $5.7M | $5.7M | $4.6M | $937K | — | View 990 |
| 2015 | $6.3M | $5.9M | $4.7M | $1.0M | — | View 990 |
| 2014 | $6.0M | $4.7M | $3.7M | $494K | — | View 990 |
| 2013 | $3.9M | $3.6M | $2.5M | $421K | — | View 990 |
| 2012 | $2.7M | $3.1M | $2.2M | $346K | — | View 990 |
| 2011 | $3.6M | $2.8M | $2.5M | $220K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $8.8M, expenses of $7.3M, and assets of $7.0M (revenue +16.8% year-over-year).
- 2022: Revenue of $7.5M, expenses of $5.8M, and assets of $6.0M (revenue +47.7% year-over-year).
- 2021: Revenue of $5.1M, expenses of $4.6M, and assets of $4.5M (revenue +42.6% year-over-year).
- 2020: Revenue of $3.6M, expenses of $3.7M, and assets of $2.6M (revenue +1.2% year-over-year).
- 2019: Revenue of $3.5M, expenses of $3.7M, and assets of $2.3M (revenue +8.7% year-over-year).
- 2018: Revenue of $3.2M, expenses of $3.8M, and assets of $2.6M (revenue -33.4% year-over-year).
- 2017: Revenue of $4.9M, expenses of $5.8M, and assets of $3.4M (revenue -14.0% year-over-year).
- 2016: Revenue of $5.7M, expenses of $5.7M, and assets of $4.6M (revenue -10.1% year-over-year).
- 2015: Revenue of $6.3M, expenses of $5.9M, and assets of $4.7M (revenue +6.0% year-over-year).
- 2014: Revenue of $6.0M, expenses of $4.7M, and assets of $3.7M (revenue +50.8% year-over-year).
- 2013: Revenue of $3.9M, expenses of $3.6M, and assets of $2.5M (revenue +46.2% year-over-year).
- 2012: Revenue of $2.7M, expenses of $3.1M, and assets of $2.2M (revenue -24.6% year-over-year).
- 2011: Revenue of $3.6M, expenses of $2.8M, and assets of $2.5M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Regenerative Research Foundation:
Data Sources and Methodology
This transparency report for Regenerative Research Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.